{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:17:58Z","timestamp":1791530278602,"version":"4.3.4"},"reference-count":85,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"vor","delay-in-days":392,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["5UL1TR002243-03"],"award-info":[{"award-number":["5UL1TR002243-03"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["5UC7AI094660-07"],"award-info":[{"award-number":["5UC7AI094660-07"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006537","name":"Vanderbilt University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN272201400058C"],"award-info":[{"award-number":["HHSN272201400058C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI142785"],"award-info":[{"award-number":["U19 AI142785"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI109711"],"award-info":[{"award-number":["U19 AI109711"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI109762"],"award-info":[{"award-number":["U19 AI109762"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007206","name":"Vanderbilt Institute for Clinical and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.cell.2021.09.035","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T10:35:17Z","timestamp":1635417317000},"page":"5593-5607.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Pan-ebolavirus protective therapy by two multifunctional human antibodies"],"prefix":"10.1016","volume":"184","author":[{"given":"Pavlo","family":"Gilchuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Murin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp A.","family":"Ilinykh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Kuzmina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoriya","family":"Borisevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystle N.","family":"Agans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan B.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth J.","family":"Zost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel S.","family":"Nargi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveenchandra","family":"Suryadevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin G.","family":"Bombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Carnahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Bukreyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James E.","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2021.09.035_bib1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nsmb.3115","article-title":"Privateer: software for the conformational validation of carbohydrate structures","volume":"22","author":"Agirre","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.cell.2021.09.035_bib2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nmeth.3541","article-title":"EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy","volume":"12","author":"Barad","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2021.09.035_bib3","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1126\/science.abd0831","article-title":"Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies","volume":"369","author":"Baum","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.09.035_bib4","first-page":"171","article-title":"Nonhuman primate models of Ebola virus disease","volume":"411","author":"Bennett","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.cell.2021.09.035_bib5","doi-asserted-by":"crossref","first-page":"W252-8","DOI":"10.1093\/nar\/gku340","article-title":"SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information","volume":"42","author":"Biasini","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2021.09.035_bib6","doi-asserted-by":"crossref","first-page":"e02154-15","DOI":"10.1128\/mBio.02154-15","article-title":"Host-primed Ebola virus GP exposes a hydrophobic NPC1 receptor-binding pocket, revealing a target for broadly neutralizing antibodies","volume":"7","author":"Bornholdt","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.cell.2021.09.035_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.chom.2018.12.005","article-title":"A two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates","volume":"25","author":"Bornholdt","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cell.2021.09.035_bib8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/515386","article-title":"A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever","volume":"178","author":"Bray","year":"1998","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.cell.2021.09.035_bib9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/infdis\/jiy199","article-title":"Anti-Ebola virus antibody levels in convalescent plasma and viral load after plasma infusion in patients with Ebola virus disease","volume":"218","author":"Brown","year":"2018","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.cell.2021.09.035_bib10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature10348","article-title":"Ebola virus entry requires the cholesterol transporter Niemann-Pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.09.035_bib11","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1110656","article-title":"Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection","volume":"308","author":"Chandran","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.09.035_bib12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/19420862.2015.1008351","article-title":"Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells","volume":"7","author":"Chng","year":"2015","journal-title":"MAbs"},{"key":"10.1016\/j.cell.2021.09.035_bib13","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1016\/j.cell.2021.06.002","article-title":"The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies","volume":"184","author":"Copin","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.09.035_bib14","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.aad5224","article-title":"Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody","volume":"351","author":"Corti","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.09.035_bib15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/infdis\/jiw209","article-title":"The Domestic Ferret (Mustela putorius furo) as a lethal infection model for 3 species of ebolavirus","volume":"214","author":"Cross","year":"2016","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.cell.2021.09.035_bib16","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.cell.2019.04.036","article-title":"Longitudinal analysis of the human B cell response to Ebola virus infection","volume":"177","author":"Davis","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.09.035_bib17","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/cid\/ciw601","article-title":"Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500\u00a0days","volume":"63","author":"Diallo","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cell.2021.09.035_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth.3286","article-title":"Atomic-accuracy models from 4.5-\u00c5 cryo-electron microscopy data with density-guided iterative local refinement","volume":"12","author":"DiMaio","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2021.09.035_bib19","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41598-017-19041-y","article-title":"A single dose of modified Vaccinia Ankara expressing Ebola virus like particles protects nonhuman primates from lethal Ebola virus challenge","volume":"8","author":"Domi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cell.2021.09.035_bib20","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.cell.2021.09.035_bib21","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJMra1901594","article-title":"Ebola","volume":"382","author":"Feldmann","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2021.09.035_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.aaa8651","article-title":"DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers","volume":"349","author":"Fibriansah","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.09.035_bib23","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2015.12.022","article-title":"Cross-reactive and potent neutralizing antibody responses in human survivors of natural ebolavirus infection","volume":"164","author":"Flyak","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.09.035_bib24","series-title":"FDA Approves First Treatment for Ebola Virus","year":"2020"},{"key":"10.1016\/j.cell.2021.09.035_bib25","series-title":"FDA Approves Treatment for Ebola Virus","year":"2020"},{"key":"10.1016\/j.cell.2021.09.035_bib26","doi-asserted-by":"crossref","first-page":"20514","DOI":"10.1038\/srep20514","article-title":"Discovery of an antibody for pan-ebolavirus therapy","volume":"6","author":"Furuyama","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cell.2021.09.035_bib27","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2021.09.035_bib28","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(19)30036-4","article-title":"Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study","volume":"393","author":"Gaudinski","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2021.09.035_bib29","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1128\/JVI.00456-08","article-title":"Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates","volume":"82","author":"Geisbert","year":"2008","journal-title":"J.\u00a0Virol."},{"issue":"Suppl 2","key":"10.1016\/j.cell.2021.09.035_bib30","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1093\/infdis\/jiv284","article-title":"Considerations in the use of nonhuman primate models of Ebola virus and Marburg virus infection","volume":"212","author":"Geisbert","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.cell.2021.09.035_bib31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.immuni.2018.06.018","article-title":"Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein","volume":"49","author":"Gilchuk","year":"2018","journal-title":"Immunity"},{"issue":"Suppl 5","key":"10.1016\/j.cell.2021.09.035_bib32","doi-asserted-by":"crossref","first-page":"S565","DOI":"10.1093\/infdis\/jiy295","article-title":"Efficacy of human monoclonal antibody monotherapy against Bundibugyo virus infection in nonhuman primates","volume":"218","author":"Gilchuk","year":"2018","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.cell.2021.09.035_bib33","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/s41551-020-0594-x","article-title":"Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics","volume":"4","author":"Gilchuk","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.cell.2021.09.035_bib34","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.immuni.2020.01.001","article-title":"Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization","volume":"52","author":"Gilchuk","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2021.09.035_bib35","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41564-018-0227-2","article-title":"The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses","volume":"3","author":"Goldstein","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.cell.2021.09.035_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.chom.2020.11.007","article-title":"Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition","volume":"29","author":"Greaney","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cell.2021.09.035_bib37","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1073\/pnas.1914985117","article-title":"Development of an antibody cocktail for treatment of Sudan virus infection","volume":"117","author":"Herbert","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2021.09.035_bib38","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1128\/JVI.02171-15","article-title":"Pan-ebolavirus and pan-filovirus mouse monoclonal antibodies: protection against Ebola and Sudan viruses","volume":"90","author":"Holtsberg","year":"2015","journal-title":"J.\u00a0Virol."},{"issue":"W1","key":"10.1016\/j.cell.2021.09.035_bib39","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","article-title":"SynergyFinder 2.0: visual analytics of multi-drug combination synergies","volume":"48","author":"Ianevski","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2021.09.035_bib40","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1128\/JVI.00101-16","article-title":"Chimeric filoviruses for identification and characterization of monoclonal antibodies","volume":"90","author":"Ilinykh","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2021.09.035_bib41","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1016\/S1473-3099(20)30282-6","article-title":"Recent successes in therapeutics for Ebola virus disease: no time for complacency","volume":"20","author":"Iversen","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.cell.2021.09.035_bib42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jmb.2016.12.004","article-title":"Arpeggio: A web server for calculating and visualising interatomic interactions in protein structures","volume":"429","author":"Jubb","year":"2017","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.cell.2021.09.035_bib43","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.coi.2018.05.001","article-title":"The structural basis for filovirus neutralization by monoclonal antibodies","volume":"53","author":"King","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cell.2021.09.035_bib83","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1128\/JVI.02172-15","article-title":"Macaque monoclonal antibodies targeting novel conserved epitopes within filovirus glycoprotein","volume":"90","author":"Keck","year":"2016","journal-title":"J. Virol"},{"key":"10.1016\/j.cell.2021.09.035_bib84","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-021-03901-9","article-title":"Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks","volume":"597","author":"Keita","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.09.035_bib44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.coviro.2019.01.003","article-title":"Achieving cross-reactivity with pan-ebolavirus antibodies","volume":"34","author":"King","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.cell.2021.09.035_bib45","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.celrep.2015.08.038","article-title":"Emergence of Ebola virus escape variants in infected nonhuman primates treated with the MB-003 antibody cocktail","volume":"12","author":"Kugelman","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2021.09.035_bib46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41579-019-0187-4","article-title":"New filovirus disease classification and nomenclature","volume":"17","author":"Kuhn","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cell.2021.09.035_bib47","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.celrep.2018.07.035","article-title":"Antibody-dependent enhancement of Ebola virus infection by human antibodies isolated from survivors","volume":"24","author":"Kuzmina","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2021.09.035_bib48","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.cell.2021.09.035_bib49","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.sbi.2009.05.004","article-title":"Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it","volume":"19","author":"Lee","year":"2009","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.cell.2021.09.035_bib50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature07082","article-title":"Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor","volume":"454","author":"Lee","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.09.035_bib51","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1056\/NEJMe1915350","article-title":"Monoclonal antibody therapy for Ebola virus disease","volume":"381","author":"Levine","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2021.09.035_bib52","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.cell.2021.09.035_bib85","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1074\/jbc.M116.767749","article-title":"Effector-attenuating substitutions that maintain antibody stability and reduce toxicity in mice","volume":"292","author":"Lo","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cell.2021.09.035_bib53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2105-5-69","article-title":"pdb-care (PDB carbohydrate residue check): a program to support annotation of complex carbohydrate structures in PDB files","volume":"5","author":"L\u00fctteke","year":"2004","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.cell.2021.09.035_bib54","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S1473-3099(19)30118-5","article-title":"Medical countermeasures during the 2018 Ebola virus disease outbreak in the North Kivu and Ituri Provinces of the Democratic Republic of the Congo: a rapid genomic assessment","volume":"19","author":"Mbala-Kingebeni","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.cell.2021.09.035_bib55","doi-asserted-by":"crossref","first-page":"e2600","DOI":"10.1371\/journal.pntd.0002600","article-title":"Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus","volume":"7","author":"Mire","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cell.2021.09.035_bib56","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.immuni.2021.01.015","article-title":"Immunotherapeutic strategies to target vulnerabilities in the Ebolavirus glycoprotein","volume":"54","author":"Misasi","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2021.09.035_bib57","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A randomized, controlled trial of Ebola virus disease therapeutics","volume":"381","author":"Mulangu","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2021.09.035_bib58","doi-asserted-by":"crossref","first-page":"108984","DOI":"10.1016\/j.celrep.2021.108984","article-title":"Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies","volume":"35","author":"Murin","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2021.09.035_bib59","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jim.2016.03.002","article-title":"A new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies","volume":"433","author":"Orlandi","year":"2016","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.cell.2021.09.035_bib60","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1371\/journal.ppat.0030009","article-title":"Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys","volume":"3","author":"Oswald","year":"2007","journal-title":"PLoS Pathog."},{"issue":"Suppl 5","key":"10.1016\/j.cell.2021.09.035_bib61","doi-asserted-by":"crossref","first-page":"S612","DOI":"10.1093\/infdis\/jiy285","article-title":"Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in nonhuman primates","volume":"218","author":"Pascal","year":"2018","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.cell.2021.09.035_bib62","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.cell.2021.09.035_bib63","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2021.09.035_bib64","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.09.035_bib86","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.virusres.2005.03.028","article-title":"Complete genome sequence of an Ebola virus (Sudan species) responsible for a 2000 outbreak of human disease in Uganda","volume":"113","author":"Sanchez","year":"2005","journal-title":"Virus Res."},{"key":"10.1016\/j.cell.2021.09.035_bib65","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cell.2018.07.033","article-title":"Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection","volume":"174","author":"Saphire","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.09.035_bib66","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S1473-3099(18)30397-9","article-title":"Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study","volume":"18","author":"Sivapalasingam","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.cell.2021.09.035_bib67","doi-asserted-by":"crossref","first-page":"100255","DOI":"10.1016\/j.xcrm.2021.100255","article-title":"Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016","volume":"2","author":"Starr","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.cell.2021.09.035_bib68","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1093\/cid\/cix210","article-title":"Dynamics of Ebola RNA persistence in semen: a report from the postebogui cohort in Guinea","volume":"64","author":"Subtil","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cell.2021.09.035_bib69","doi-asserted-by":"crossref","first-page":"16142","DOI":"10.1038\/nmicrobiol.2016.142","article-title":"Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA","volume":"1","author":"Thi","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.cell.2021.09.035_bib70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2004.10.048","article-title":"Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening","volume":"332","author":"Towner","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.cell.2021.09.035_bib71","doi-asserted-by":"crossref","first-page":"e1000212","DOI":"10.1371\/journal.ppat.1000212","article-title":"Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda","volume":"4","author":"Towner","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cell.2021.09.035_bib72","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1500306","article-title":"Persistence of Ebola virus in ocular fluid during convalescence","volume":"372","author":"Varkey","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2021.09.035_bib74","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.09.035_bib75","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.cell.2017.04.037","article-title":"Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses","volume":"169","author":"Wec","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.09.035_bib76","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.chom.2018.12.004","article-title":"Development of a human antibody cocktail that deploys multiple functions to confer pan-ebolavirus protection","volume":"25","author":"Wec","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cell.2021.09.035_bib77","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41594-019-0191-4","article-title":"Structural basis of broad ebolavirus neutralization by a human survivor antibody","volume":"26","author":"West","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.cell.2021.09.035_bib79","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/279246a0","article-title":"Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule","volume":"279","author":"Yewdell","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.09.035_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","article-title":"Gctf: Real-time CTF determination and correction","volume":"193","author":"Zhang","year":"2016","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.cell.2021.09.035_bib80","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2017.04.038","article-title":"Immunization-elicited broadly protective antibody reveals ebolavirus fusion loop as a site of vulnerability","volume":"169","author":"Zhao","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.09.035_bib81","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nmeth.4193","article-title":"MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy","volume":"14","author":"Zheng","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2021.09.035_bib82","doi-asserted-by":"crossref","first-page":"e42166","DOI":"10.7554\/eLife.42166","article-title":"New tools for automated high-resolution cryo-EM structure determination in RELION-3","volume":"7","author":"Zivanov","year":"2018","journal-title":"eLife"}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009286742101165X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009286742101165X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:15:28Z","timestamp":1777475728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009286742101165X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":85,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S009286742101165X"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2021.09.035","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pan-ebolavirus protective therapy by two multifunctional human antibodies","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2021.09.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}